Eastern Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$140M Sell
116,336
-9,169
-7% -$9.37M 2.14% 12
2026
Q1
$115M Sell
125,505
-4,239
-3% -$4.3M 1.98% 13
2025
Q4
$139M Buy
129,744
+906
+0.7% +$866K 2.41% 10
2025
Q3
$98.3M Buy
128,838
+5,164
+4% +$3.84M 1.75% 16
2025
Q2
$96.4M Buy
123,674
+15,293
+14% +$11.9M 1.84% 14
2025
Q1
$89.5M Buy
108,381
+18,102
+20% +$15.1M 1.75% 15
2024
Q4
$69.7M Buy
90,279
+222
+0.2% +$184K 1.3% 18
2024
Q3
$79.8M Buy
90,057
+53,426
+146% +$48M 1.43% 16
2024
Q2
$33.2M Buy
36,631
+634
+2% +$507K 1.34% 18
2024
Q1
$28M Buy
35,997
+5,884
+20% +$4.19M 1.17% 29
2023
Q4
$17.6M Sell
30,113
-170
-0.6% -$99.2K 0.8% 49
2023
Q3
$16.3M Buy
30,283
+18,449
+156% +$9.51M 0.81% 49
2023
Q2
$5.55M Buy
11,834
+30
+0.3% +$12.6K 0.26% 84
2023
Q1
$4.05M Sell
11,804
-230
-2% -$77.6K 0.2% 91
2022
Q4
$4.4M Sell
12,034
-937
-7% -$332K 0.24% 82
2022
Q3
$4.19M Buy
12,971
+251
+2% +$79.5K 0.24% 83
2022
Q2
$4.12M Sell
12,720
-372
-3% -$112K 0.22% 86
2022
Q1
$3.75M Sell
13,092
-1,991
-13% -$512K 0.17% 92
2021
Q4
$4.17M Sell
15,083
-270
-2% -$68.4K 0.18% 91
2021
Q3
$3.55M Buy
15,353
+10,544
+219% +$2.6M 0.17% 93
2021
Q2
$1.1M Sell
4,809
-293
-6% -$58.9K 0.05% 128
2021
Q1
$953K Sell
5,102
-1,211
-19% -$237K 0.05% 130
2020
Q4
$1.07M Buy
6,313
+71
+1% +$10.6K 0.06% 116
2020
Q3
$924K Sell
6,242
-778
-11% -$120K 0.06% 116
2020
Q2
$1.15M Hold
7,020
0.07% 106
2020
Q1
$974K Sell
7,020
-59
-0.8% -$8.11K 0.07% 110
2019
Q4
$930K Sell
7,079
-22
-0.3% -$2.55K 0.05% 108
2019
Q3
$794K Sell
7,101
-307
-4% -$34.2K 0.05% 113
2019
Q2
$821K Hold
7,408
0.05% 118
2019
Q1
$961K Sell
7,408
-350
-5% -$42.6K 0.06% 118
2018
Q4
$898K Sell
7,758
-410
-5% -$45.8K 0.07% 114
2018
Q3
$876K Sell
8,168
-4,000
-33% -$400K 0.06% 120
2018
Q2
$1.04M Sell
12,168
-62
-0.5% -$5.09K 0.07% 118
2018
Q1
$946K Sell
12,230
-187
-2% -$15.1K 0.07% 129
2017
Q4
$1.05M Buy
12,417
+239
+2% +$20.3K 0.07% 122
2017
Q3
$1.04M Buy
12,178
+262
+2% +$21.5K 0.07% 118
2017
Q2
$980K Sell
11,916
-501
-4% -$40.9K 0.07% 118
2017
Q1
$1.04M Buy
12,417
+208
+2% +$16.7K 0.08% 117
2016
Q4
$898K Buy
12,209
+170
+1% +$12.7K 0.07% 121
2016
Q3
$966K Sell
12,039
-115
-0.9% -$9.21K 0.08% 116
2016
Q2
$957K Sell
12,154
-146
-1% -$11K 0.08% 116
2016
Q1
$886K Sell
12,300
-216
-2% -$16.3K 0.07% 118
2015
Q4
$1.05M Sell
12,516
-21,871
-64% -$1.81M 0.09% 111
2015
Q3
$2.88M Sell
34,387
-352
-1% -$29.7K 0.25% 76
2015
Q2
$2.9M Sell
34,739
-388
-1% -$29.6K 0.23% 77
2015
Q1
$2.55M Sell
35,127
-945
-3% -$67.3K 0.2% 84
2014
Q4
$2.49M Buy
36,072
+194
+0.5% +$13.1K 0.2% 85
2014
Q3
$2.33M Buy
35,878
+1,324
+4% +$83.8K 0.19% 88
2014
Q2
$2.15M Sell
34,554
-173
-0.5% -$10.3K 0.17% 92
2014
Q1
$2.04M Buy
34,727
+4,582
+15% +$256K 0.17% 86
2013
Q4
$1.54M Buy
30,145
+1,872
+7% +$93.7K 0.13% 94
2013
Q3
$1.42M Sell
28,273
-18,590
-40% -$973K 0.13% 95
2013
Q2
$2.3M Buy
+46,863
New +$2.55M 0.21% 77

Other funds holding LLY

Eastern Bank's LLY Position: Q2 2026 in Review

Eastern Bank reduced its Eli Lilly (LLY) stake by 7.3% in Q2 2026, selling an estimated $9.37M and leaving 116,336 shares worth $140M. The position accounts for 2.14% of the portfolio, ranked #12.

Eastern Bank first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Eastern Bank held 116,336 shares of Eli Lilly worth $140M as of Q2 2026.
  • Eastern Bank sold 9,169 Eli Lilly shares in Q2 2026, an estimated $9.37M.
  • Eli Lilly made up 2.14% of Eastern Bank's portfolio in Q2 2026, its #12 holding.
  • Eastern Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.